title: Is pentoxifylline a viable alternative in the treatment of ENL?
authors.forename: E N
authors.initials: EN
authors.lastname: Sarno
authors.forename: J A
authors.initials: JA
authors.lastname: Nery
authors.forename: C C
authors.initials: CC
authors.lastname: Garcia
authors.forename: E P
authors.initials: EP
authors.lastname: Sampaio
mesh_terms: D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015439:Leprosy, Borderline / Q000188:drug therapy; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D008297:Male; D010431:Pentoxifylline / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline